1. Academic Validation
  2. Mechanism of antifungal activity and therapeutic action of β-ionone on Aspergillus fumigatus keratitis via suppressing LOX1 and JNK/p38 MAPK activation

Mechanism of antifungal activity and therapeutic action of β-ionone on Aspergillus fumigatus keratitis via suppressing LOX1 and JNK/p38 MAPK activation

  • Int Immunopharmacol. 2022 Sep;110:108992. doi: 10.1016/j.intimp.2022.108992.
Min Yin 1 Cui Li 2 Leyuan Zhang 1 Lina Zhang 1 Jing Lin 1 Nan Jiang 1 Qain Wang 1 Qiang Xu 1 Hengrui Zheng 1 Lingwen Gu 1 Yiyi Jia 1 Bing Yu 1 Guiqiu Zhao 3
Affiliations

Affiliations

  • 1 Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
  • 2 Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China. Electronic address: [email protected].
  • 3 Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China. Electronic address: [email protected].
Abstract

Purpose: To investigate the anti-inflammatory and Antifungal role of β-ionone (BI) in Fungal keratitis (FK).

Methods: In vitro Antifungal activity of BI against Aspergillus fumigatus (A. fumigatus) was evaluated by using minimum inhibitory concentration (MIC), crystal violet staining, biofilm biomass measurement, propidium iodide uptake test, and adherence assay. And RT-PCR was carried out to measure the levels of RodA, RodB, Rho, FKs, CshA-D, RlmA, Cyp51A-B and Cdr1B. Network pharmacology analysis was applied to predict the relationship between BI and FK. Cell Count Kit-8 (CCK8) assay was utilized to detect the cytotoxicity of BI to RAW264.7 and immortalized human corneal epithelial cells (HCECs). The underlying mechanism of BI at regulating the level of inflammatory factors in FK was assessed by RT-PCR, ELISA and Western blot in vitro and in vivo. The therapeutic effect of BI has investigated in A. fumigatus keratitis by employing the clinical score, pathological examination, plate count, immunofluorescence and myeloperoxidase (MPO) assay. We also used the slit-lamp microscopy, clinical scores, and HE staining to assess the effect of natamycin compared with BI treatment in vivo.

Results: BI suppressed the growth of A. fumigatus and had a significant effect on A. fumigatus biofilms and membrane permeability. RT-PCR demonstrated that exposure of A. fumigatus to BI inhibited the expression of genes that function in hydrophobin (RodA, RodB), cell wall integrity (Rho, FKs, CshA-D, RlmA), azole susceptibility (Cyp51A-B, Cdr1B). Network pharmacology showed that the effects of BI in FK implicate with C-type lectin receptor signaling pathway. In vivo, after A. fumigatus Infection, BI treatment markedly reduced the severity of FK by decreasing clinical score, neutrophil recruitment, and Fungal load. And BI treatment also obviously reduced the expression of inflammatory cytokines, Lectin-like oxidized LDL receptor (LOX-1), phosphorylation of p38MAPK and p-JNK versus the DMSO-treated group. BI and natamycin both significantly increased corneal transparency and decreased inflammatory cell recruitment in the FK in the mice model.

Conclusion: These results indicated that BI had fungicidal activities against A. fumigatus. It also ameliorated FK in mice by reducing inflammation, which was regulated by LOX-1, p-p38MAPK and p-JNK.

Keywords

Anti-inflammatory; Fungal keratitis; Fungicidal effect; LOX-1; β-ionone.

Figures